Plotkin's Vaccines (7th Ed.)

Auteur :

Langue : Anglais

299,93 €

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

Ajouter au panierAjouter au panier
Date de parution :
Ouvrage 1720 p. · Relié
From the development of each vaccine to its use in reducing disease, Plotkin’s Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development.

Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field.
Section 1: General aspects of vaccination
. 1. A short history of vaccination
. 2. Vaccine immunology
. 3. Correlates of protection
. 4. The vaccine industry
. 5. Vaccine manufacturing
. 6. Evolution of adjuvants across the centuries
. 7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
. 8. Passive immunization
. 9. General immunization practices

Section 2: Licensed Vaccines and Vaccines in Development  
. 10. Adenovirus vaccines
. 11. Anthrax vaccines
. 12. Biodefense and special pathogen vaccines
. 13. Cancer vaccines
. 14. Cholera vaccines
. 15. Combination vaccines
. 16. Cytomegalovirus vaccines
. 17. Dengue vaccines
. 18. Diarrhea caused by bacteria
. 19. Diphtheria toxoid
. 20. Ebola vaccines
. 21. Enterovirus 71
. 22. Epstein-Barr virus vaccines
. 23. Haemophilus influenzae type b vaccines
. 24. Hepatitis A vaccines
. 25. Hepatitis B vaccines
. 26. Hepatitis C vaccines
. 27. Hepatitis E vaccines
. 28. Herpes simplex virus vaccines
. 29. Human immunodeficiency virus vaccines
. 30. Human papillomavirus vaccines
. 31. Inactivated influenza vaccines
. 32. Influenza vaccine—live
. 33. Japanese encephalitis vaccines
. 34. Lyme disease vaccines
. 35. Malaria vaccines
. 36. Maternal immunization
. 37. Measles vaccine
. 38. Meningococcal Capsular A, C, W, and Y Conjugate Vaccines
. 39. Mumps vaccines
. 40. Noninfectious disease vaccines
. 41. Norovirus
. 42. Parasitic disease vaccines
. 43. Pertussis vaccines
. 44. Plague vaccines
. 45. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
. 46. Pneumococcal polysaccharide vaccines
. 47. Poliovirus vaccine—inactivated
. 48. Poliovirus vaccine—live
. 49. Rabies vaccines
. 50. Respiratory syncytial virus vaccines
. 51. Rotavirus vaccines
. 52. Rubella vaccine
. 53. Smallpox and vaccinia
. 54. Staphylococcus aureus vaccines
. 55. Streptococcus group A vaccines
. 56. Streptococcus group B vaccines
. 57. Tetanus toxoid
. 58. Tick-borne encephalitis virus vaccines
. 59. Tuberculosis vaccines
. 60. Typhoid fever vaccines
. 61. Varicella vaccine
. 62. Yellow fever vaccine
. 63. Zoster vaccine

Section 3: New Technologies  
. 64. Technologies for making new vaccines
. 65. The development of gene-based vectors for immunization
. 66. Technologies to Improve Immunization

Section 4: Vaccination of special groups  
. 67. Vaccination of immunocompromised hosts
. 68. Vaccination of human immunodeficiency virus-infected persons
. 69. Vaccines for international travel
. 70. Vaccines for health care personnel

Section 5: Public health and regulatory issues 
. 71. Immunization in the United States
. 72. Immunization in Europe
. 73. Immunization in the Asia-Pacific region
. 74. Immunization in developing countries
. 75. Community Protection
. 76. Economic analyses of vaccine policies
. 77. Regulation and testing of vaccines
. 78. Regulation of vaccines in Europe
. 79. Regulation of vaccines in low and middle-income countries
. 80. Vaccine safety
. 81. Legal issues
. 82. Ethics

Appendix
Stanley Plotkin
Emeritus Professor of Pediatrics, University of Pennsylvania, Emeritus Professor, Wistar Institute, Former Chief, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA - Former Medical and Scientific Director, Pastuer Merieux Connaught (now Sanofi Pasteur), Marnes-la-Coquette, France